CLINICAL MICROBIOLOGY REVIEWS

Scope & Guideline

Navigating the landscape of epidemiology and immunology.

Introduction

Welcome to your portal for understanding CLINICAL MICROBIOLOGY REVIEWS, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN0893-8512
PublisherAMER SOC MICROBIOLOGY
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1988 to 2024
AbbreviationCLIN MICROBIOL REV / Clin. Microbiol. Rev.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1752 N ST NW, WASHINGTON, DC 20036-2904

Aims and Scopes

The journal 'Clinical Microbiology Reviews' serves as a comprehensive platform for disseminating critical reviews and insights into the field of clinical microbiology. It aims to enhance understanding of microbial infections, their management, and the evolving challenges posed by antimicrobial resistance and emerging pathogens.
  1. Clinical Microbiology and Infectious Disease Management:
    Focuses on the diagnosis, treatment, and prevention of infectious diseases, providing updates on clinical practices and laboratory methods.
  2. Antimicrobial Resistance and Stewardship:
    Addresses the growing concern of antimicrobial resistance, exploring mechanisms, implications for treatment, and strategies for stewardship in clinical settings.
  3. Microbiome Research:
    Investigates the role of the human microbiome in health and disease, emphasizing its implications for treatment and prevention strategies.
  4. Emerging Pathogens and Public Health Concerns:
    Covers newly identified pathogens and their public health implications, including responses to outbreaks and the development of vaccines.
  5. Innovative Therapeutic Approaches:
    Highlights novel treatment modalities and technologies, including phage therapy, mRNA vaccines, and bioengineering strategies for infectious disease management.
  6. Clinical Laboratory Innovations:
    Focuses on advancements in laboratory diagnostics, biosafety, and methodologies that enhance the detection and management of infectious diseases.
The journal is currently witnessing a surge in specific themes that reflect the dynamic landscape of clinical microbiology and infectious disease research. These emerging areas are crucial for addressing contemporary challenges in the field.
  1. COVID-19 and Viral Infections:
    Research related to COVID-19, including diagnostics, treatment strategies, and public health responses, has seen a significant increase following the pandemic.
  2. Microbiome and Health Interactions:
    The exploration of the human microbiome's role in health, disease, and therapeutic outcomes is gaining traction, highlighting its importance in clinical practice.
  3. Innovations in Vaccine Development:
    There is a growing emphasis on novel vaccine technologies, particularly mRNA vaccines, in response to emerging infectious diseases and public health needs.
  4. Antimicrobial Resistance Strategies:
    A heightened focus on understanding and combating antimicrobial resistance, including novel therapeutic approaches and stewardship practices, is emerging.
  5. Public Health Surveillance and Preparedness:
    Research on surveillance methodologies, including wastewater-based surveillance and responses to outbreaks, is increasingly relevant in the context of global health security.

Declining or Waning

While 'Clinical Microbiology Reviews' continues to evolve, certain themes have become less prominent over recent years. This decline may reflect shifts in research focus or advancements in other areas of microbiology.
  1. Traditional Antibiotics:
    Research on conventional antibiotic treatments is declining as the field pivots towards exploring alternatives and addressing antibiotic resistance.
  2. Non-Emerging Infectious Diseases:
    Infectious diseases that have been historically well-managed (e.g., certain bacterial infections) are receiving less attention compared to emerging threats like COVID-19 and antimicrobial resistance.
  3. Basic Microbiology Research:
    There is a noticeable shift away from fundamental microbiological studies towards more clinical and applied research, reflecting the journal's focus on direct clinical implications.
  4. Single-Pathogen Studies:
    Focus on studies of individual pathogens is waning as there is a growing interest in co-infections, interactions within the microbiome, and systems biology approaches.

Similar Journals

European Journal of Microbiology and Immunology

Bridging Gaps in Immunology Research
Publisher: AKADEMIAI KIADO ZRTISSN: 2062-8633Frequency: 4 issues/year

Welcome to the European Journal of Microbiology and Immunology, a premier platform dedicated to advancing the field of microbiology and immunology through the dissemination of high-quality research. Published by AKADEMIAI KIADO ZRT in Hungary, this journal serves as an essential resource for researchers, professionals, and students alike, fostering scholarly communication and innovation in these critical areas of medical science. The journal, which holds an ISSN of 2062-8633, presents rigorously peer-reviewed articles that contribute to our understanding of microbial diseases, immune responses, and related fields, currently ranking in the Q2 and Q3 quartiles across multiple categories such as immunology and microbiology. By embracing an inclusive scholarly dialogue and offering a robust readership, the European Journal of Microbiology and Immunology aims to inspire the next wave of discoveries and collaborations within the global scientific community.

Jundishapur Journal of Microbiology

Exploring the frontiers of infectious disease research.
Publisher: BRIEFLANDISSN: 2008-3645Frequency: 12 issues/year

Welcome to the Jundishapur Journal of Microbiology, a peer-reviewed publication dedicated to advancing the field of microbiology. Published by BRIEFLAND, this journal focuses on key areas such as infectious diseases and medical microbiology, offering a platform for researchers to share their findings from 2009 to 2024. Despite its current positioning in Quartile 4 across various categories in 2023, the journal provides a valuable resource for budding scientists and established professionals alike, contributing to the growing body of knowledge in these critical areas. While it is not an open-access journal, the Jundishapur Journal prioritizes the dissemination of research in the Netherlands, facilitating a deeper understanding of microbial science and its implications for public health. Join a community of innovators committed to exploring both emerging and established themes in microbiology.

Revista Espanola de Quimioterapia

Exploring Breakthroughs in Therapeutic Strategies
Publisher: SOCIEDAD ESPANOLA QUIMIOTERAPIAISSN: 0214-3429Frequency: 6 issues/year

The Revista Espanola de Quimioterapia, published by the SOCIEDAD ESPANOLA QUIMIOTERAPIA, is a pivotal open-access journal that has been advancing the field of clinical microbiology and pharmacology since its inception in 1989. With an E-ISSN of 1988-9518, this journal caters to a diverse audience of researchers, healthcare professionals, and students, providing them with critical insights into the latest developments in medicinal chemistry and therapeutic strategies. Located in Madrid, Spain, the journal reflects the rigorous academic standards of its associated institutions, contributing significantly to the translation of research into clinical practice. Achieving a Q3 ranking in the fields of Medicine, Microbiology, and Pharmacology in 2023 attests to its growing influence and relevance in the scientific community, making it a vital resource for those engaged in the quest for innovative solutions to pressing healthcare challenges. The journal prides itself on its commitment to maintaining an open-access model since 2018, ensuring that vital research is freely accessible to foster greater knowledge sharing and collaboration within the global scientific community.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Leading the charge in infectious diseases research.
Publisher: ELSEVIER TAIWANISSN: 1684-1182Frequency: 6 issues/year

Welcome to the Journal of Microbiology Immunology and Infection, a premier academic publication established in 1998 and now proudly owned by Elsevier Taiwan. As an Open Access journal since 2016, it provides unrestricted access to groundbreaking research in the fields of immunology, microbiology, and infectious diseases, making it an essential resource for researchers, practitioners, and students alike. The journal holds impressive rankings, including Q1 status in categories such as Infectious Diseases and Microbiology (medical), and a notable 92nd percentile in its Scopus ranking for Medicine - Infectious Diseases. With a dedicated focus on advancing knowledge and fostering collaboration within the scientific community, the Journal of Microbiology Immunology and Infection is committed to publishing high-impact research that significantly influences practice and policy in healthcare and life sciences. The journal is also recognized for its contribution to the ongoing dialogue surrounding contemporary issues in immunology and infection, positioning it as a vital platform for scholarly exchange and innovation.

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA

Connecting researchers to the pulse of immunology.
Publisher: AKADEMIAI KIADO ZRTISSN: 1217-8950Frequency: 4 issues/year

ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA is a distinguished academic journal published by AKADEMIAI KIADO ZRT, focusing on significant advancements in the fields of microbiology, immunology, and infectious diseases. Established in 1994, this journal serves as a vital platform for researchers, professionals, and students keen on exploring the complexities of microbial interactions and immune responses. With a current Impact Factor reflecting its rank within the Q3 categories for Immunology, Microbiology, and Infectious Diseases, it retains a critical position in disseminating innovative research. Although not open access, the journal provides extensive insights disseminated through various academic databases, ensuring a broad reach within the scholarly community. Its convergence over three decades indicates a robust commitment to excellence in scientific inquiry and knowledge sharing. As it moves towards the future, ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA continues to uphold its legacy of fostering collaborative research initiatives that contribute to the understanding and treatment of microbial diseases globally.

Gut Pathogens

Fostering Innovation in Gut Pathogen Research
Publisher: BMCISSN: 1757-4749Frequency: 1 issue/year

Gut Pathogens, published by BMC in the United Kingdom, is a premier open-access journal focusing on the intersection of gut health and infectious diseases. With its impact firmly established since its inception in 2009, the journal has earned impressive rankings, including Q1 in renowned categories such as Gastroenterology, Infectious Diseases, Microbiology, and Parasitology, while maintaining a strong presence in Virology. The journal serves as a vital resource for researchers, professionals, and students interested in the intricate relationships between gut microbiota and pathogenic organisms, offering insights that drive advancements in treatment and prevention strategies. By providing unrestricted access to high-quality research, Gut Pathogens fosters a collaborative environment, encouraging the dissemination of knowledge and innovation within the field. The journal publishes original research, reviews, and case studies, all designed to address contemporary challenges in gut health, ultimately aiming to improve patient outcomes and public health worldwide.

New Microbiologica

Driving impactful research for a healthier tomorrow.
Publisher: EDIZIONI INT SRLISSN: 1121-7138Frequency: 4 issues/year

New Microbiologica is a prominent academic journal published by EDIZIONI INT SRL, dedicated to advancing knowledge in the fields of Microbiology and Medicine. Since its inception in 1993, this journal has played a vital role in disseminating cutting-edge research, featuring articles that explore the intricate relationships between microorganisms and human health. With an H-index indicating a robust citation profile and a respectable 2023 Scopus Ranking placing it in the 32nd percentile for medicine microbiology, New Microbiologica resonates well within the academic community. Although not an Open Access journal, it is strategically positioned in Quartile 3 of both Medicine (miscellaneous) and Medical Microbiology categories, which reflects its importance to researchers and professionals seeking valuable insights in their fields. Published in Italy, the journal continues to provide a platform for impactful research through its commitment to high-quality publications, fostering collaboration and innovation among scientists and academics in the ever-evolving landscape of microbiological studies.

Mediterranean Journal of Infection Microbes and Antimicrobials

Exploring the intricate world of microbes and health.
Publisher: GALENOS PUBL HOUSEISSN: 2147-673XFrequency: 1 issue/year

Mediterranean Journal of Infection Microbes and Antimicrobials is a distinguished open-access journal published by GALENOS PUBL HOUSE, dedicated to advancing the understanding of infectious diseases and microbiology. Since its inception in 2011, this journal has been a vital resource for researchers, professionals, and students interested in the intricate world of microbes and their impacts on human health. With its ISSN 2147-673X, the journal has progressively gained visibility, although it currently holds a Q4 ranking in multiple categories including Immunology and Microbiology, and Infectious Diseases for the year 2023. The journal operates from its headquarters in Istanbul, Turkey, and features a rich array of articles that contribute to the field’s body of knowledge. As a platform enhancing the accessibility of research, it invites submissions from global contributors to foster collaboration and innovation in tackling microbial challenges.

Flora Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Dergisi

Championing open access to vital research in infection control.
Publisher: BILIMSEL TIP YAYINEVIISSN: 1300-932XFrequency: 4 issues/year

Flora Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Dergisi, published by BILIMSEL TIP YAYINEVI, is a leading journal dedicated to the field of infection diseases and clinical microbiology. With an ISSN of 1300-932X and an E-ISSN of 2602-2842, this journal has been an established Open Access platform since 1999, allowing researchers worldwide to access critical studies and advancements without barriers. The journal aims to disseminate high-quality research articles, reviews, and case studies that address emerging challenges in infection management and microbiological practices. By fostering a collaborative environment for professionals, researchers, and students alike, Flora Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Dergisi plays a vital role in advancing knowledge and practices within the microbiological and clinical spheres. Its commitment to open access ensures that invaluable resources are widely available, supporting the growth and development of innovation in the medical field.

MICROBIOLOGY AND IMMUNOLOGY

Pioneering Discoveries in the World of Microbes and Immunity
Publisher: WILEYISSN: 0385-5600Frequency: 12 issues/year

MICROBIOLOGY AND IMMUNOLOGY, an esteemed journal published by WILEY, serves as a vital resource for researchers and professionals in the fields of microbiology, immunology, and virology. With its ISSN 0385-5600 and E-ISSN 1348-0421, this journal has been a cornerstone in scientific literature since its inception in 1977, bridging decades of research and innovation through its comprehensive coverage of emerging trends and discoveries. Although this journal operates without open access, it maintains a commendable presence in academic circles, reflected in its 2023 Quartile rankings of Q3 across the categories of Immunology, Microbiology, and Virology. As part of an important discourse in these disciplines, MICROBIOLOGY AND IMMUNOLOGY ensures its scholarly contributions are relevant to both seasoned researchers and emerging scholars. Positioned in a competitive journal landscape, with Scopus ranks indicating a median percentile across its fields, it remains committed to advancing knowledge through peer-reviewed articles, thereby supporting the continuous evolution of its focus areas. The journal's current scope encompasses topics critical for understanding pathogen-host interactions and the immune response, making it a crucial publication for any academic library or individual scholar dedicated to the biological sciences.